Friday, August 25, 2017

SynAgile Lands $10.4M

Wilson, Wyoming-based a href="http://www.synagile.com">SynAgile, a pharmaceuticals firm developing continuous, drug delivery systems for L-DOPA and carbidopa--used to treat Parkinson's disease--has raised $10.4M in funding, the company said this week. The funding was led by TAMCAP LLC. According to SynAgile, the new funding will go towards its first, in-human, Phase 2 clinical trial.